Compounds > methamphetamine

methamphetamine and Cerebral Cryptococcosis

methamphetamine has been researched along with Cerebral Cryptococcosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eugenin, EA; Frases, S; Greco, JM; Martinez, LR; Nosanchuk, JD1
Cao, H; Chi, F; Huang, SH; Jong, A; Liu, LQ; Peng, L; Wang, SF; Wu, CH; Yu, JY; Zhang, B1

Other Studies

2 other study(ies) available for methamphetamine and Cerebral Cryptococcosis

ArticleYear
Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans.
    The Journal of infectious diseases, 2013, Aug-15, Volume: 208, Issue:4

    Topics: Animals; Blood-Brain Barrier; Brain; Cell Adhesion Molecules; Central Nervous System Stimulants; Cryptococcus neoformans; Female; Immunosuppressive Agents; Meningitis, Cryptococcal; Methamphetamine; Mice; Mice, Inbred C57BL; Protein Biosynthesis; Survival Analysis; Tight Junction Proteins

2013
Alpha7 nicotinic acetylcholine receptor is required for blood-brain barrier injury-related CNS disorders caused by Cryptococcus neoformans and HIV-1 associated comorbidity factors.
    BMC infectious diseases, 2015, Aug-19, Volume: 15

    Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Coinfection; Cryptococcus neoformans; HIV Envelope Protein gp41; HIV Infections; HIV-1; Inflammation; Meningitis, Cryptococcal; Methamphetamine; Mice; Mice, Knockout; NF-kappa B; Nicotinic Antagonists

2015